Looking Into Immunogen's Return On Capital Employed By: Benzinga via Benzinga November 28, 2022 at 09:49 AM EST Immunogen (NASDAQ:IMGN) brought in sales totaling $15.38 million during Q3 according to data provided by Benzinga Pro. However, earnings ... Read More >> Related Stocks: ImmunoGen, Inc. - Common Stock